NCT06546449View on ClinicalTrials.gov

LH-001 vs Placebo in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 5, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Healthy
Interventions
DRUG

LH-001

LH-001 will be administered oral

DRUG

Placebo

Placebo will be administered oral

Trial Locations (1)

43221

RECRUITING

The Ohio State University, Columbus

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Chien-Liang Lin

OTHER

NCT06546449 - LH-001 vs Placebo in Healthy Participants | Biotech Hunter | Biotech Hunter